Table 3 The clinical characteristics and CA 19 − 9 level of the HbA1c ≥ 9% group and control group
Variables | The HbA1c ≥ 9% group (n = 186) | Non-diabetes controls (n = 200) | p value |
|---|---|---|---|
CA 19−9 levels (U/ml) | 22.0 ± 17.4 | 13.6 ± 8.9 | < 0.001* |
Proportion of objects with abnormal CA 19−9 | 26/186 (14.0%) | 5/200 (2.5%) | < 0.001* |
Age (years) | 55.4 ± 13.3 | 57.5 ± 14.2 | 0.153 |
Female sex | 49 (26.3%) | 64 (32.0%) | 0.222 |
BMI (kg/m2) | 24.8 ± 3.7 | 25.4 ± 3.8 | 0.587 |
HbA1c (%) | 11.37 ± 1.91 | 4.8 ± 1.02 | < 0.001* |
Systolic blood pressure (mmHg) | 128.9 ± 20.2 | 130.1 ± 15.6 | 0.438 |
Diastolic blood pressure (mmHg) | 81.5 ± 12.1 | 76.8 ± 11.9 | 0.267 |
Uric acid (µmol/l) | 305.7 ± 94.2 | 326.5 ± 91.2 | 0.122 |
Total cholesterol (mmol/l) | 4.77 ± 1.27 | 4.68 ± 1.39 | 0.382 |
Triglycerides (mmol/l) | 2.02 ± 1.82 | 1.93 ± 1.74 | 0.424 |
Creatinine (µmol/l) | 64.6 ± 23.2 | 67.6 ± 15.3 | 0.125 |
ALT (U/L) | 26.6 ± 17.6 | 26.9 ± 18.2 | 0.691 |